Brief: Implantica Q1 Operating Loss At EUR 3.9 Mln
22/05/2026 07:10
May 22 (Reuters) - Implantica AG 8IM1q.F: Q1 NET SALES INCREASE 15% TO TEUR 857 Q1 OPERATING LOSS (EBIT) IMPROVES TO TEUR 3,858 Source text: ID:nWkr8XMYRw Further company coverage: [8IM1q.F] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Implantica AG
See all newsBrief: Implantica Q1 Operating Loss At EUR 3.9 Mln
Brief: Implantica Gives Final Response To FDA For PMA Application
Brief: Implantica Announces Adoption Of Refluxstop At Careggi University Hospital
Brief: Implantica - FDA Provides Feedback On Refluxstop PMA Module 3
Brief: Implantica Says FDA Provides Favorable Feedback On Refluxstop Pma Module 3